BDBM8732 (2E)-N-methyl-N-[(1-methyl-1H-indol-2-yl)methyl]-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)prop-2-enamide::(E)-N-Methyl-N-(1-methyl-1H-indol-2-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide::indole naphthyridinone 21
SMILES: CN(Cc1cc2ccccc2n1C)C(=O)\C=C\c1cnc2NC(=O)CCc2c1
InChI Key: InChIKey=TVPFKRZTBLHFFW-JXMROGBWSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Enoyl-ACP Reductase (FabI) (Staphylococcus aureus) | BDBM8732 ((2E)-N-methyl-N-[(1-methyl-1H-indol-2-yl)methyl]-3...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 50 | n/a | n/a | n/a | n/a | 6.5 | 30 |
GlaxoSmithKline | Assay Description Assays were carried out in half-area, 96-well microtiter plates. Compounds were evaluated in assay mixtures containing components specific for each e... | J Med Chem 46: 1627-35 (2003) Article DOI: 10.1021/jm0204035 BindingDB Entry DOI: 10.7270/Q2DB8018 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-ACP Reductase (FabI) (Haemophilus influenzae) | BDBM8732 ((2E)-N-methyl-N-[(1-methyl-1H-indol-2-yl)methyl]-3...) | KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 560 | n/a | n/a | n/a | n/a | n/a | 30 |
GlaxoSmithKline | Assay Description Assays were carried out in half-area, 96-well microtiter plates. Compounds were evaluated in assay mixtures containing components specific for each e... | J Med Chem 46: 1627-35 (2003) Article DOI: 10.1021/jm0204035 BindingDB Entry DOI: 10.7270/Q2DB8018 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-ACP Reductase (FabI) (Escherichia coli) | BDBM8732 ((2E)-N-methyl-N-[(1-methyl-1H-indol-2-yl)methyl]-3...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 139 | n/a | n/a | n/a | n/a | n/a | n/a |
Affinium Pharmaceuticals Inc. Curated by ChEMBL | Assay Description Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumption | Bioorg Med Chem Lett 19: 5355-8 (2009) Article DOI: 10.1016/j.bmcl.2009.07.129 BindingDB Entry DOI: 10.7270/Q21G0Q2B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-ACP Reductase (FabI) (Staphylococcus aureus) | BDBM8732 ((2E)-N-methyl-N-[(1-methyl-1H-indol-2-yl)methyl]-3...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
Affinium Pharmaceuticals Inc. Curated by ChEMBL | Assay Description Inhibition of Staphylococcus aureus FabI | Bioorg Med Chem Lett 19: 5355-8 (2009) Article DOI: 10.1016/j.bmcl.2009.07.129 BindingDB Entry DOI: 10.7270/Q21G0Q2B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-ACP Reductase (FabI) (Escherichia coli) | BDBM8732 ((2E)-N-methyl-N-[(1-methyl-1H-indol-2-yl)methyl]-3...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
Affinium Pharmaceuticals Inc. Curated by ChEMBL | Assay Description Inhibition of Escherichia coli FabI | Bioorg Med Chem Lett 19: 5359-62 (2009) Article DOI: 10.1016/j.bmcl.2009.07.094 BindingDB Entry DOI: 10.7270/Q2571FT3 | |||||||||||
More data for this Ligand-Target Pair |